These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

34 related articles for article (PubMed ID: 24300751)

  • 21. A 24-week, randomized, controlled trial of adjunctive sibutramine versus topiramate in the treatment of weight gain in overweight or obese patients with bipolar disorders.
    McElroy SL; Frye MA; Altshuler LL; Suppes T; Hellemann G; Black D; Mintz J; Kupka R; Nolen W; Leverich GS; Denicoff KD; Post RM; Keck PE
    Bipolar Disord; 2007 Jun; 9(4):426-34. PubMed ID: 17547588
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Second phase of a double-blind study clinical trial on Sibutramine for the treatment of patients suffering essential obesity: 6 months after treatment cross-over.
    Fanghänel G; Cortinas L; Sánchez-Reyes L; Berber A
    Int J Obes Relat Metab Disord; 2001 May; 25(5):741-7. PubMed ID: 11360159
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by beta-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trial.
    Sramek JJ; Leibowitz MT; Weinstein SP; Rowe ED; Mendel CM; Levy B; McMahon FG; Mullican WS; Toth PD; Cutler NR
    J Hum Hypertens; 2002 Jan; 16(1):13-9. PubMed ID: 11840225
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sibutramine in the treatment of antipsychotic-induced weight gain: a pilot study in patients with schizophrenia.
    Biedermann F; Fleischhacker WW; Kemmler G; Ebenbichler CF; Lechleitner M; Hofer A
    Int Clin Psychopharmacol; 2014 May; 29(3):181-4. PubMed ID: 24300751
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Weight gain during treatment with antipsychotics: clinical relevance, pathophysiology, and therapeutical strategies].
    Himmerich H; Schuld A; Pollmächer T
    Psychiatr Prax; 2004 Nov; 31 Suppl 2():S233-7. PubMed ID: 15586316
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of adjunctive ranitidine for antipsychotic-induced weight gain: A systematic review of randomized placebo-controlled trials.
    Gu XJ; Chen R; Sun CH; Zheng W; Yang XH; Wang SB; Ungvari GS; Ng CH; Golenkov A; Lok GKI; Li L; Chow IHI; Wang F; Xiang YT
    J Int Med Res; 2018 Jan; 46(1):22-32. PubMed ID: 28718688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Schizophrenia and weight management: a systematic review of interventions to control weight.
    Faulkner G; Soundy AA; Lloyd K
    Acta Psychiatr Scand; 2003 Nov; 108(5):324-32. PubMed ID: 14531752
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metformin for weight reduction in non-diabetic patients on antipsychotic drugs: a systematic review and meta-analysis.
    Björkhem-Bergman L; Asplund AB; Lindh JD
    J Psychopharmacol; 2011 Mar; 25(3):299-305. PubMed ID: 20080925
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Topiramate and Metformin Are Effective Add-On Treatments in Controlling Antipsychotic-Induced Weight Gain: A Systematic Review and Network Meta-Analysis.
    Zhuo C; Xu Y; Liu S; Li J; Zheng Q; Gao X; Li S; Jing R; Song X; Yue W; Zhou C; Upthegrove R
    Front Pharmacol; 2018; 9():1393. PubMed ID: 30546312
    [No Abstract]   [Full Text] [Related]  

  • 30.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 31.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 32.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.